Regulus Therapeutics Inc. (RGLS) Return On Equity % [USD] 2013 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regulus Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2024.
  • Regulus Therapeutics Inc. Return On Equity for the quarter ending March 31, 2024 was -65.7 %, a 18.9% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Equity for 2023 was -109 %, a 58.6% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Equity for 2022 was -68.8 %, a 8.46% increase from 2021.
  • Regulus Therapeutics Inc. annual Return On Equity for 2021 was -75.2 %, a 31.6% increase from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -65.7 +15.3 +18.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -109 -40.4 -58.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -94.2 -32.7 -53.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -85.4 -17.6 -26% Apr 1, 2023 Jun 30, 2023
Q1 2023 -81 -13.9 -20.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68.8 +6.36 +8.46% Oct 1, 2022 Dec 31, 2022
Q3 2022 -61.6 +12.4 +16.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -67.8 -6.79 -11.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -67.1 +23.9 +26.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -75.2 +34.7 +31.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -74 +76.7 +50.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -61 +153 +71.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -91 +124 +57.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -110 +291 +72.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -151 -1.37 K -112% Jul 1, 2020 Sep 30, 2020
Q2 2020 -214 -2.15 K -111% Apr 1, 2020 Jun 30, 2020
Q1 2020 -215 +163 K +99.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -401 +270 +40.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 1.22 K +1.53 K Jul 1, 2019 Sep 30, 2019
Q2 2019 1.94 K +2.14 K Apr 1, 2019 Jun 30, 2019
Q1 2019 -163 K -163 K -76086% Jan 1, 2019 Mar 31, 2019
Q4 2018 -671 -469 -233% Oct 1, 2018 Dec 31, 2018
Q3 2018 -312 -122 -64.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -205 -32.3 -18.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -214 -88.4 -70.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -202 -101 -100% Oct 1, 2017 Dec 31, 2017
Q3 2017 -190 -119 -170% Jul 1, 2017 Sep 30, 2017
Q2 2017 -173 -117 -209% Apr 1, 2017 Jun 30, 2017
Q1 2017 -126 -75 -147% Jan 1, 2017 Mar 31, 2017
Q4 2016 -101 -58.8 -140% Oct 1, 2016 Dec 31, 2016
Q3 2016 -70.4 -17.8 -33.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -56.1 -0.53 -0.95% Apr 1, 2016 Jun 30, 2016
Q1 2016 -51 +2.71 +5.04% Jan 1, 2016 Mar 31, 2016
Q4 2015 -42.1 +17.5 +29.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.6 -9.99 -23.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -55.6 -23.8 -74.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -53.7 -24.4 -83% Jan 1, 2015 Mar 31, 2015
Q4 2014 -59.6 -34.1 -134% Oct 1, 2014 Dec 31, 2014
Q3 2014 -42.6 -6.54 -18.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -31.8 +61.7 +66% Apr 1, 2014 Jun 30, 2014
Q1 2014 -29.4 Jan 1, 2014 Mar 31, 2014
Q4 2013 -25.5 Oct 1, 2013 Dec 31, 2013
Q3 2013 -36.1 Jul 1, 2013 Sep 30, 2013
Q2 2013 -93.5 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.